However, patient‐derived lung cancer organoids are more effective than 3D spheroid systems for estimating the clinical effect of EHMT1 expression in lung cancer patients because cancer organoids more accurately resemble cancer cells and the tumor environment [28, 29]. The gene discussed is EHMT1; the disease is neoplasm.